These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15243108)

  • 41. Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
    Chlebicki MP; Oh HM
    Ann Acad Med Singap; 2004 May; 33(3):302-6. PubMed ID: 15175768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands.
    van der Bij AK; Peirano G; Goessens WH; van der Vorm ER; van Westreenen M; Pitout JD
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3576-8. PubMed ID: 21502612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
    J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Romero L; López L; Rodríguez-Baño J; Ramón Hernández J; Martínez-Martínez L; Pascual A
    Clin Microbiol Infect; 2005 Aug; 11(8):625-31. PubMed ID: 16008614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
    Siu LK; Lu PL; Hsueh PR; Lin FM; Chang SC; Luh KT; Ho M; Lee CY
    J Clin Microbiol; 1999 Dec; 37(12):4020-7. PubMed ID: 10565924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli.
    Hsieh CJ; Shen YH; Hwang KP
    J Microbiol Immunol Infect; 2010 Jun; 43(3):240-8. PubMed ID: 21291853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
    Kim YK; Pai H; Lee HJ; Park SE; Choi EH; Kim J; Kim JH; Kim EC
    Antimicrob Agents Chemother; 2002 May; 46(5):1481-91. PubMed ID: 11959586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
    Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J
    J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Burden of Extended-Spectrum β-Lactamase-Producing
    Sawatwong P; Sapchookul P; Whistler T; Gregory CJ; Sangwichian O; Makprasert S; Jorakate P; Srisaengchai P; Thamthitiwat S; Promkong C; Nanvatthanachod P; Vanaporn M; Rhodes J
    Am J Trop Med Hyg; 2019 Apr; 100(4):943-951. PubMed ID: 30793684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.
    Hung WT; Cheng MF; Tseng FC; Chen YS; Shin-Jung Lee S; Chang TH; Lin HH; Hung CH; Wang JL
    J Microbiol Immunol Infect; 2019 Dec; 52(6):947-955. PubMed ID: 31076319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.
    Yan JJ; Ko WC; Tsai SH; Wu HM; Jin YT; Wu JJ
    J Clin Microbiol; 2000 Dec; 38(12):4320-5. PubMed ID: 11101558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and epidemiological relationship of CMY-2 AmpC β-lactamase and CTX-M extended-spectrum β-lactamase-producing Escherichia coli isolates from broiler farms in Japan.
    Kameyama M; Chuma T; Yabata J; Tominaga K; Iwata H; Okamoto K
    J Vet Med Sci; 2013; 75(8):1009-15. PubMed ID: 23503164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
    Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High prevalence of B2-ST131 clonal group among extended-spectrum β-lactamase-producing Escherichia coli isolated from bloodstream infections in Quito, Ecuador.
    Zurita J; Solís MB; Ortega-Paredes D; Barba P; Paz Y Miño A; Sevillano G
    J Glob Antimicrob Resist; 2019 Dec; 19():216-221. PubMed ID: 31077859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.